PATRICK HOWELL: Open Payments
NPI 1174293518 · EAST NORRITON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,234 in 106 payments from 22 companies in 2025. Trend: 2023 $348 · 2024 $2,083 · 2025 $2,234
Food & beverage: $2,234
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $492 |
| Astellas Pharma US Inc | 9 | $246 |
| Otsuka America Pharmaceutical, Inc. | 12 | $240 |
| Novo Nordisk Inc | 11 | $192 |
| Sumitomo Pharma America, Inc. | 8 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $142 |
| PFIZER INC. | 6 | $125 |
| Lundbeck LLC | 4 | $80 |
| Exact Sciences Corporation | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $75 |
Products named: REXULTI, AIRSUPRA, Veozah, FARXIGA, GEMTESA, XIFAXAN, NURTEC ODT, Wegovy.
Industry payments across PA — which companies pay providers there.
